Literature DB >> 21926931

Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.

Lucia Costa-Paiva1, Carlos E Godoy, Armando Antunes, Joyce D Caseiro, Michael Arthuso, Aarao M Pinto-Neto.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prevalence of endometrial premalignant and malignant polyps in premenopausal and postmenopausal women, as well as the clinical, ultrasound, and hysteroscopic factors associated with malignancy.
METHODS: All women undergoing hysteroscopic resection of endometrial polyps from January 1998 to December 2008 were selected using a computerized database from the operating theater of the Prof. Dr. José Aristodemo Pinotti Women's Hospital, Women's Health Care Center/University of Campinas. Eight hundred seventy women with ages ranging from 25 to 85 years were included. Polyps were classified into benign (endometrial polyps and polyps with nonatypical simple hyperplasia and nonatypical complex hyperplasia), premalignant (polyps with atypical simple hyperplasia or atypical complex hyperplasia), and malignant. Statistical analysis was performed by measurement of the frequencies, means, and SD. The risk factors for malignancy were assessed by bivariate and multiple regression analyses, using the Epi-Info 2000 program and SAS (Statistical Analysis Software), version 9.2.
RESULTS: The mean (SD) age of the women was 57.5 (10.6) years. Of these women, 76.4% were postmenopausal. Women were diagnosed with benign lesions in 95.8% of cases. Premalignant polyps accounted for 1.6% of the total number of cases. Malignant polyps represented 2.5% of the total sample. Postmenopausal bleeding and age greater than 60 years were the only factors that remained associated with a higher risk of malignancy with a prevalence ratio of 3.67 (95% CI, 1.69-7.97) and 1.5 (95% CI, 1.01-1.09), respectively.
CONCLUSIONS: The prevalence rate of malignancy in endometrial polyps was higher in women with postmenopausal bleeding and advanced age.

Entities:  

Mesh:

Year:  2011        PMID: 21926931     DOI: 10.1097/gme.0b013e31821e23a1

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  14 in total

1.  The value of hysteroscopic biopsy in the diagnosis of endometrial polyps.

Authors:  Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Leonardo Vieira Elias; Nilton José Leite; Waldir Pereira Modotti; Ricardo Bassil Lasmar; Rogério Dias
Journal:  Womens Health (Lond)       Date:  2016-07

2.  Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps.

Authors:  Andrea Ciavattini; Jacopo DI Giuseppe; Nicolò Clemente; Lorenzo Moriconi; Giovanni Delli Carpini; Nina Montik; Laura Mazzanti
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

3.  Investigation of the Roles of Cyclooxygenase-2 and Galectin-3 Expression in the Pathogenesis of Premenopausal Endometrial Polyps.

Authors:  Esin Kasap; Serap Karaarslan; Esra Bahar Gur; Mine Genc; Nur Sahin; Serkan Güclü
Journal:  J Pathol Transl Med       Date:  2016-04-16

4.  Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen.

Authors:  Se Jeong Jeon; Jae Il Lee; Maria Lee; Hee Seung Kim; Jae Weon Kim; Noh Hyun Park; Yong Sang Song
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

5.  HISTOPATHOLOGIC FINDINGS IN WOMEN UNDERGOING HYSTEROSCOPIC RESECTION OF ENDOMETRIAL POLYPS AND UTERINE MYOMAS.

Authors:  Hrvojka Soljačić Vraneš; Ivka Djaković; Marija Vrljičak; Nives Đurić Orsag; Krunoslav Kuna; Zdenko Kraljević; Tanja Leniček; Ivan Brlečić
Journal:  Acta Clin Croat       Date:  2019-12       Impact factor: 0.780

6.  Concurrent primary peritoneal low-grade serous carcinoma and endometrial high-grade serous carcinoma.

Authors:  Megan G Lockyer; Michael T Deavers; Neda Zarrin-Khameh
Journal:  Int J Gynecol Pathol       Date:  2015-05       Impact factor: 2.762

7.  Endometrial polyps in female allograft recipients with abnormal bleedings.

Authors:  Dariusz Rajski; Katarzyna Bobrowska; Bronisława Pietrzak; Mirosław Wielgoś; Paweł Kamiński
Journal:  Prz Menopauzalny       Date:  2014-06-30

8.  Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients.

Authors:  Armando Antunes; José Vassallo; Anderson Pinheiro; Rogério Leão; Aarão Mendes Pinto Neto; Lucia Costa-Paiva
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

9.  Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy.

Authors:  Marco Antonio Lenci; Vanessa Alessandra Lui do Nascimento; Ana Beatriz Grandini; Walid Makin Fahmy; Daniella de Batista Depes; Fausto Farah Baracat; Reginaldo Guedes Coelho Lopes
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

10.  Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and -9 in endometrial polyps and endometrial cancer type I.

Authors:  Gustavo Filipov Peres; Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Nilton José Leite; Leonardo Vieira Elias; Maria Aparecida Custódio Domingues; Carlos Roberto Padovani; Rogério Dias
Journal:  Onco Targets Ther       Date:  2018-07-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.